EUVIMEDEUVIMED entdecken
Crossref

IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development

Wenjuan Chen, Xingyun Xie, Chengying Liu, Jingrong Liao, Yuting Wei, Rongrong Wu, Jinsheng Hong

Cellular Signalling · 2024

DOI: 10.1016/j.cellsig.2024.111192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2024. Verfasst von Wenjuan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, PR China; Department of Radiotherapy, …. Hauptthemen laut MEDLINE: Interleukin-1 Receptor-Associated Kinases, Uterine Cervical Neoplasms, NF-kappa B, Apoptosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IRAK1 has been implicated in promoting development of various types of cancers and mediating radioresistance. However, its role in cervical cancer tumorigenesis and radioresistance, as well as the potential underlying mechanisms, remain poorly defined. In this study, we evaluated IRAK1 expression in radiotherapy-treated cervical cancer tissues and found that IRAK1 expression is negatively associated with the efficacy of radiotherapy. Consistently, ionizing radiation (IR)-treated HeLa and SiHa cervical cancer cells express a lower level of IRAK1 than control cells. Depletion of IRAK1 resulted in reduced activation of the NF-κB pathway, decreased cell viability, downregulated colony formation efficiency, cell cycle arrest, increased apoptosis, and impaired migration and invasion in IR-treated cervical cancer cells. Conversely, overexpressing IRAK1 mitigated the anti-cancer effects of IR in cervical cancer cells. Notably, treatment of IRAK1-overexpressing IR-treated HeLa and SiHa cells with the NF-κB pathway inhibitor pyrrolidine dithiocarbamate (PDTC) partially counteracted the effects of excessive IRAK1. Furthermore, our study demonstrated that IRAK1 deficiency enhanced the anti-proliferative role of IR treatment in a xenograft mouse model. These collective observations highlight IRAK1's role in mitigating the anti-cancer effects of radiotherapy, partly through the activation of the NF-κB pathway. SUMMARY: IRAK1 enhances cervical cancer resistance to radiotherapy, with IR treatment reducing IRAK1 expression and increasing cancer cell vulnerability and apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-1 Receptor-Associated KinasesUterine Cervical NeoplasmsNF-kappa BApoptosisHumansFemaleAnimalsMiceHeLa CellsCell ProliferationMice, NudeCell Line, TumorSignal TransductionCell MovementRadiation ToleranceXenograft Model Antitumor AssaysCell SurvivalRadiation, Ionizing

Stichwörter der Autor:innen

Cervical cancerHeLaIntracellular receptor-associated kinase 1 (IRAK1)NF-κBRadiotherapySiHaXenograft

Substanzen

Interleukin-1 Receptor-Associated KinasesIRAK1 protein, humanNF-kappa B

Autor:innen und Institutionen

  • Department of Radiotherapy, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, PR China; Department of Radiotherapy, Gynecology, Clinical Oncology School of Fujian Medical University, Fuj…
  • Department of Radiotherapy, Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, Fujian, PR China.
  • Laboratory of Radiation Oncology and Radiobiology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, Fujian, PR China.
  • Department of Radiotherapy, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, PR China; National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical U…

Zitieren

APA

Chen, W., Xie, X., Liu, C., Liao, J., Wei, Y., Wu, R., & Hong, J. (2024). IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111192

Vancouver

Chen W, Xie X, Liu C, Liao J, Wei Y, Wu R, et al. IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111192

BibTeX
@article{Chen2024,
  author = {Chen, Wenjuan and Xie, Xingyun and Liu, Chengying and Liao, Jingrong and Wei, Yuting and Wu, Rongrong and Hong, Jinsheng},
  title = {IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development},
  journal = {Cellular Signalling},
  year = {2024},
  doi = {10.1016/j.cellsig.2024.111192}
}
Kostenlos starten →